Abstract The impact of local structure on mRNA translation is not well-defined pertaining to the 5 0 UTR. Reports suggest structural remodelling of the 5 0 UTR can significantly influence mRNA translation both in cis and trans however a new layer of complexity has been applied to this model with the now known reversible post-transcriptional chemical modification of RNA. N 6 -methyladenosine (m 6 A) is the most abundant internal base modification in mammalian mRNA. It has been reported that mRNAs harbouring m 6 A motifs in their 5 0 UTR have improved translation efficiency. The present study evaluated the addition of putative m 6 A motifs to the 5 0 UTR of a model recombinant human therapeutic glycoprotein, Erythropoietin (EPO), in a direct comparison with an A to T mutant and a no adenosine control. The m 6 A construct yielded significantly improved EPO titer in transient batch culture over no adenosine and m 6 T controls by 2.84 and 2.61-fold respectively. This study highlights that refinement of transgene RNA elements can yield significant improvements to protein titer.
Introduction
RNA forms complex secondary and tertiary structures with known examples of structure-directed function (Leppek et al. 2018) . Predicting the impact of cisregulatory sequences of non-coding scripts, such as un-translated regions (UTR), on mRNA translation in higher eukaryotes remains a challenge. Recent growing appreciation for functional heterogeneity between eukaryotic ribosomal complexes and its associated proteins (Simsek et al. 2017; Shi et al. 2017 ) coupled with evidence of mRNA-structure-influenced translation raises the question: how much regulatory potential is owed to mRNA structure and structure-directed recruitment of RNA-binding protein (RBP) translation-driving factors? (Topisirovic et al. 2011; Pichon et al. 2012; Manning and Cooper 2017) . For this reason, the structure of UTR sequence in transgene expression cassettes may offer ''playgrounds'' for synthetic engineering of transgene expression. Early studies to synthetically remodel the 5 0 un-translated region (UTR) of transgene mRNA (Kozak 1986; Grens and Scheffler 1990) indicated highly-stable GCrich secondary duplexes (DG = -50 kcal/mol) upstream of the initiation AUG triplet prevented scanning of the 40S ribosome subunit leading to reduced protein yield. And complete removal 5 0 UTR sequence comes with the caveat of omitting known translational enhancer elements, impacting negatively on mRNA translation (Stein et al. 1998) .
Reversible epigenetic modifications to both genomic DNA (Suzuki and Bird 2008) and histone proteins (StrahI and Allis 2000) have been known to influence gene expression and regulate cellular behaviour. Recent discovery of the intermediary member of the central dogma, RNA, having similar reversible chemical tuning has redefined how RNA metabolism is viewed (He 2010; Fu et al. 2014) . The most abundant internal mRNA modification in mammalian cells is N 6 -methyladenosine (m 6 A) (Wei et al. 1975) . Transcriptome analysis of human cells and mouse tissue have revealed m 6 A consensus motifs to be in the form
6 A motifs are present in coding regions, 3 0 or 5 0 UTRs of mRNAs (Dominissini et al. 2012; Meyer et al. 2012 ) and in non-coding RNA (ncRNA) scripts (Wei et al. 1975) with enriched abundance at stop codons (Huang et al. 2018 ). This discovery of RNA chemical tuning adds a new layer of complexity to our understanding of how UTR sequence and structures can regulate mRNA translation.
In mammalian cells, m 6 A is generated by a multicomponent methyltransferase ''writer''-complex comprised of; METTL3, METTL14 and WTAP (Liu et al. 2014; Ping et al. 2014 ). This reaction is reversible with the ''eraser'' proteins FTO (Jia et al. 2011 ) and ALKBH5 (Zheng et al. 2013) . Both writer and eraser modifications occur in the cell nucleus. The molecular mechanisms underpinning how m 6 A motifs are recognised by different known m 6 A-RNA binding proteins (RBPs) and regulate m 6 A-RNA fate is still poorly understood. It has been reported that the stability of m 6 A-modified mRNA is under dynamic regulation by three cytoplasmic ''reader'' proteins of the YTH domain family, YTHDF1-3 (Wang et al. 2015) . The crystal structure of YTHDF2's YTH domain revealed the m 6 A recognition site (Zhu et al. 2014) as an aromatic cage . The m 6 A reader YTHDF2 recognises m 6 A marked mRNA and selectively reduces the stability of such messages . The mechanism by which YTHDF2 destabilises mRNA harbouring m 6 A was revealed to be mediated by accelerated transcript deadenylation via the CCR4-NOT complex (Du et al. 2016) . While YTHDF2 controls the turnover of m 6 A containing mRNA, YTHDF1-mediates enhanced translational efficiency of m 6 A containing scripts (Wang et al. 2015) . This mechanism of epigenetic post-transcriptional control permits the cell to prioritise the protein synthesis of m 6 A marked mRNAs. Contrary to the mRNA-decay-promoting action of YTHDF2, IGF2BPs 1-3 have been identified as a family of m 6 A readers that promote target mRNA stability and translation (Huang et al. 2018 ). The consensus m 6 A recognition motif differs slightly between YTHDF and IGF2BPs with the nucleotide at position -3 to the A being A/U for YTHDF and U/C for IGF2BP. This selective recognition of different m 6 A-RBP families adds to the complexity of posttranscriptional epigenetic regulation.
Independent studies have demonstrated that the presence of consensus putative m 6 A motifs in the 5 0 UTR of transgene mRNA significantly improves the transcript's translation efficiency in both cap-independent (Meyer et al. 2015; Yang et al. 2017 ) and capdependent (Wang et al. 2015) manners in human cells. Moreover, the location of a single m 6 A motif in the 5 0 UTR significantly impacts the mRNAs' translation with close-proximity to the gene start codon giving the highest protein production (Meyer et al. 2015 ). An understudied area in industrial biotechnology has been improving the protein coding potential of transgene mRNA in mammalian production hosts. While codon optimisation has improved the rate of elongation, selectively biasing the host to initiate transgene protein synthesis and or increase mRNA stability could significantly enhance recombinant protein yields.
Materials and methods

Plasmid construction and transcript analysis
The human EPO open reading frame was synthesised (GenScript) with one of; a putative m 6 A-GGACTA AAGCGGACTTGT, m 6 T-GGTCTAAAGCGGTC TTGT, or no adenosine control sequence-CGGTGCCGGTGC, taken from (Yang et al. 2017) . These constructs were cloned into in a pcDNA-3.1 (?) Hygromycin (Invitrogen) backbone using HindIII and EcoRV sites. RNA secondary structure was predicted with RNAFold (http://rna.tbi.univie.ac.at/cgi-bin/ RNAWebSuite/RNAfold.cgi). Tertiary RNA structure was predicted using RNAComposer (http:// rnacomposer.cs.put.poznan.pl/) and sequence features highlighted using PyMOL V2.2.
Cell culture and transfection CHO-K1 (ATCC) were grown in Balan CD Growth A (Irvine Scientific) with (2.52 g L -1 ) polyvinyl alcohol (PVA), and sub-cultured every 72-96 h. Cultures were maintained in a Climo-Shaker (Kühner), 37°C, 80% humidity and 5% CO 2 with routine seeding at 2 9 10 5 cells mL -1 in 50 mL spin tube (TPP). Cell growth and viability was monitored using the Guava EasyCyte ViaCount programme (Merck Millipore). Prior to transfection, cells were washed twice with CHO S SFM II (Gibco) and seeded at 1 9 10 6 cells mL -1 in 2 mL of CHO S SFM II. Transfection was performed in accordance with the MIRUS Transit 2X protocol. In brief, a complex of a [1:2] ratio lg pDNA to lL transfection reagent was formed in 100 lL of pre-warmed, 37°C, CHO S SFM II, for 30 min. Transfection complexes were then added to the cell suspension and incubated for 24 h. All transfections were done using a ratio of 1 lg of plasmid DNA per 1 9 10 6 cells. 24 h post transfection the cultures were washed twice in Balan CD Growth A with PVA and seeded at 3 9 10 5 cells mL -1 in triplicate 5 mL cultures.
RNA isolation
Transfected cells were harvested by centrifugation at 919g for 5 min. Cell pellets were washed in phosphate buffered saline (PBS) and centrifuged again. Total RNA was isolated from 1 to 5 9 10 6 cells using 1 mL of Tri-reagent (Ambion) with no divergence from the manufacturer's protocol. RNA quantification and quality were evaluated by NanoDrop (Thermo Scientific). To remove contaminating plasmid DNA, RNA samples were treated with DNase I (Sigma Aldrich) as per manufacturer's protocol. qPCR Reverse transcription of total RNA was performed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) in accordance with the manufacture's protocol. RT-qPCR was performed on an AB7500 (Applied Biosystems) using Fast SYBR Green Master Mix (Applied Biosystems). The 2X SYBR master mix was combined with 20 ng of cDNA, 200 nM forward and reverse primers, and water made up to 20 lL final reaction volume. Each biological replicate sample was run in technical triplicate wells. Primer sequences used are as follows; Gapdh FW-TGGCTACAGCAACAGAGTGG, Gapdh RV-GTGAGGGAGATGATCGGTGT, hEPO FW-ACTTGTCTCGAGATGGGGGT, hEPO RV-AGGTACCTCTCCAGGACTCG, HYG RW-ATGCTCCGCATTGGTCTTGA, HYG RV-ATTTGTGTACGCCCGACAGT. Relative quantification of PCR products was calculated using the ddCt method with Gapdh as an endogenous control and HYG as a control of transfection efficiency. Error was calculated as the standard deviation of three biological replicates.
ELISA
Secreted EPO was quantified by enzyme linked immunosorbent assay (ELISA) of cell culture supernatant. Culture supernatant was harvested by centrifugation of cell suspension at 919g for 5 min. NuncImmuno TM MicroWell TM 96 well solid plates (M9410 Sigma-Aldrich) were coated with 100 lL of capture antibody MAB-287 (R&D Systems), diluted 1:500 in coating buffer (C3041-50CAP) (Sigma-Aldrich) for 2 h at 4°C. Plate washing consisted of 3 9 100 lL per well washes of ELISA wash buffer (T9039) (Sigma-Aldrich). Blocking was done for 1 h at room temperature with (T6789) Blocking Buffer (SigmaAldrich). Standards of recombinant human EPO (Cat no. 329871) (Merck Millipore) were diluted to range from 8000 to 0 pg mL -1 in sample dilution buffer (T6789 ? 0.05% Tween20) (Sigma-Aldrich). Samples were diluted to fall within the range of standard curve and 100 lL incubated on the plate at 37°C for 1 h. Rabbit Immunoglobulin-HRP (P0448) (Dako, Agilent) diluted 1:2000 was used for detection, 100 lL per well was incubated for 1 h at room temperature. 100 lL of development solution; 1.2 mL of 3,3 0 ,5,5 0 -
Tetramethylbenzidin at 1 mg mL -1 in DMSO, 2.4 lL 30% (v/v) hydrogen peroxide and 10.8 mL PhosphateCitrate buffer (P4809) (Merck), was added to each well and incubated for 30 min. The reaction was stopped by adding 100 lL 0.18 M H 2 SO 4 to each well. Protein concentration was determined by reading on a Multi-scan Go (Thermo Fisher Scientific) and samples concentrations quantified using linear regression of the standard curve. Analysis consisted of six technical replicates over three biological replicates.
Results
It has been previously reported that m 6 A motifs are significantly enriched in known circRNAs (Yang et al. 2017) . In their study, Yang et al. (2017) demonstrated dramatic increases in the translation efficiency of circular mRNAs containing m 6 A motifs upstream of a reporter-gene start codon in direct comparison to an A to T mutant and to a no adenosine control (No A CTRL). To investigate the potential of m 6 A motifs improving the production efficiency of recombinant protein therapeutics in CHO cells, we cloned three variants up-stream of a recombinant human Erythropoietin (rhEPO) open reading frame (Fig. 1) .
The three transcript variants; No A-CTRL, m 6 T and m 6 A were assessed by transient batch performance in a CHO-K1 host. There was no significant difference in peak cell density between the transcript variants and un-transfected (CHO-K1) and transfection reagent only (vehicle) controls (Fig. 2a) . Nor were there any deleterious effects on cell viability (Fig. 2b) . Secreted EPO was monitored by ELISA of culture supernatant harvested at 48 h intervals. Cell specific productivity (Qp) was highest in the m 6 A variant (Fig. 2c) . The mean Qp of CHO-K1 cells was improved to (9.31 pg cell -1 day -1 ) with m 6 A from (3.84 pg cell -1 day -1 ) in the No A control (p = 0.00048) and (3.56 pg cell -1 day -1 ) m 6 T (p = 0.00019). Accordingly, mean EPO titer was improved significantly in the m 6 A variant at all time points of analysis over both m 6 T and No A controls (Fig. 2d) . The m 6 A construct increased the mean secreted EPO titer to (13.6 lg mL -1 ) from that of m 6 T (5.5 lg mL -1 ) (p = 0.000487) and No A (5.7 lg mL -1 ) (p = 0.000185) at 48 h into culture (Fig. 2d) . Expression of EPO mRNA with the m 6 A variant culminated in a final increase at 144 h of 2.61-fold over m 6 T (p = 0.0042) and 2.84-fold over the No A control (p = 0.0029) (Fig. 2d) .
The exact function of m 6 A in eukaryotic translation is not fully understood with independent reports describing its role in an mRNA's translation efficiency (Wang et al. 2015) and mRNA turnover or stability Du et al. 2016; Huang et al. 2018 ). The vectors used in this study drive the expression of a resistance gene Hygromycin-B-phosphotransferase (HYG) under a PKG promoter. Relative quantification (RQ) of HYG mRNA was assessed at 48, 96 and 144 h and normalized to that of the No A control at each time point with respect to the endogenous control Gapdh in all cases (Fig. 3a) . There was no significant difference between any of the three constructs at any time point indicating similar transfection efficiencies in all cases (Fig. 3a) . The relative EPO mRNA abundance was (Fig. 3b) . Relative to the No A control at each time point the m 6 T transcript variant remained higher with a 4.16-fold (p = 7.1 9 10 -5 ) and 3.45-fold (p = 1.76 9 10 -6 ) increase in mRNA abundance at 96 and 144 h time points respectively (Fig. 3b) . Similarly, EPO mRNA abundance in the m 6 A variant remained higher than the No A control with a 3.43-fold (p = 0.00027) and 3.84-fold (p = 1.46 9 10 -5 ) increase in mRNA abundance at 96 and 144 h time points respectively (Fig. 3b) . With transient transfection transgene expression decreases over time with the dilution of plasmid DNA as cells divide. There was no significant difference in the rate of HYG mRNA abundance decreasing over time between constructs (Fig. 3c) . The Log 2 fold decrease in EPO mRNA abundance showed a significantly different profile for -5 ), (p = 7.923 9 10 -6 ) respectively between 96 and 144 h (Fig. 3d) .
The three transcript variants used in this study contain subtle sequence differences, yet the relative mRNA abundance and subsequent translation differed greatly. The secondary structure of all transcript variants was analysed using RNAFold (Fig. 4a) . There was similar structure present in the m 6 T and m 6 A constructs, but these differed greatly from the distinct open structure of the No A control (Fig. 4a) . RNAComposer was used to predict the tertiary structure of these differing structures. The open loop structed remained in the tertiary model of the No A control (Fig. 4b) . Again, there was a highly similar appearance between the m 6 T (Fig. 4c ) and m 6 A variants (Fig. 4d) .
Discussion
We present herein an observation of significantly improved recombinant titer with modifications of the 5 0 UTR of transgene mRNA. Employing a putative m 6 A motif previously reported to significantly improve the cap-independent translation of circular mRNAs (Yang et al. 2017) in human cell lines. Here we report it to have a similar effect on the translation of linear EPO mRNA in CHO-K1 cells with higher Qp (Fig. 2c) resulting in increased secreted EPO titer (Fig. 2d) . In transient batch culture we observed no deleterious effects on peak cell density (Fig. 2a) or cell viability (Fig. 2b ) associated with any of the three transcript variants. It would be interesting to see if this positive impact on product titer would hold through in stable mixed pools or clonal studies. Also, the sequence variants lack a consensus Kozak motif, which is known to enhance translation. Future work should incorporate the use of a Kozak sequence in the 5 0 UTR design. Simple addition of the Kozak motif may not be sufficient as the inclusion of extra nucleotides would disrupt the 5 0 UTR secondary structure.
Perhaps the most interesting finding was the dramatic increase in EPO mRNA transcript variants harbouring putative m 6 T and m 6 A motifs (Fig. 3b) . Normalizing for transfection efficiency with HYG mRNA, the m 6 T and m 6 A EPO mRNA variants had relative increases in abundance in the order of 4.14 and 4.99-fold, respectively over the No A control (Fig. 3b) . The rate of m 6 T and m 6 A mRNA loss with transient delivery was significantly reduced compared to that of the No A control (Fig. 3d) . Given that the loss of HYG mRNA was similar in all cases (Fig. 3c) and that RNA methylation is said to occur post- transcriptionally , this suggests that the increase in mRNA abundance is due to enhanced stability rather than improved transcription. Analysing the 5 0 UTR secondary folding of the three transcript variants (Fig. 4) revealed a highly similar structure for both m 6 T and m 6 A but these two differ greatly from the No A control. Variable translation efficiencies between the m 6 A and m 6 T suggest that the differences can be attributed to the putative methylation of a single nucleotide substitution. Recent evidence by Liu et al. (2015) described the presence of m 6 A conferred changes to mRNA secondary structure. Their data suggests that methylation and demethylation resulted in dynamic remodelling of local mRNA structures terming this ''the m 6 A switch'' (Liu et al. 2015) . Restructuring of the m 6 A transcript variant to include methylation is not possible with current RNA folding software but this could explain the improved translation observed with the m 6 A over the m 6 T transcript variants.
To date, apart from circularization of transcript mRNA (Wesselhoeft et al. 2018) , efforts to improve the stability of linear transgene mRNA have yielded modest returns (Ferizi et al. 2015; Holtkamp et al. 2006) . The m 6 A motif used in this study contains a U/C at the -3 position which was found to be an enriched motif from the consensus with IGF2BPs (Huang et al. 2018) . As described by Huang et al., (2018) , recognition of m 6 A by IGF2BPs enhanced mRNA stability. This could be an explanation for why the putative m 6 A mRNA in this study had such improved relative mRNA abundance. Although we must point out this may also stem from the highly stable hairpin structures formed in the m 6 T (DG = -32.30) and m 6 A (DG = -30.40) variants over that of the No A control (DG = -17.90). It is probable this increased mRNA abundance is a combination of both for the m 6 A variant and can be attributed to the highly stable hairpin in the m 6 T script. Reports of reversible m 6 A writing, erasing and reading (Liu et al. 2014; Ping et al. 2014; Jia et al. 2011; Zheng et al. 2013; Wang et al. 2014; Huang et al. 2018) point to this mechanism of post-transcriptional regulation being highly tuneable. As of yet it has not been reported if m 6 A writers, erasers and readers are dynamic between different stages of culture in CHO cells. If this is the case, transgene mRNA encoding selective putative m 6 A motifs could be conditionally translated under defined culture stages. With a report of targeted epigenetic editing of genomic DNA using a dCas9-GCN4 peptide fusion (Morita et al. 2016 ) and newly reported ssRNA targeting CRISPR proteins, Cas13b (Cox et al. 2017 ) the potential for targeted epigenetic regulation of transgene mRNA in mammalian hosts could offer new components to the mammalian cell engineering toolbox. 
